ELVN EPS Estimates
Enliven Therapeutics, Inc.
$40.98
+$0.35(+0.86%)
45
Overall
60
Value
36
Tech
39
Quality
Market Cap
$3.00B
Volume
1.00M
52W Range
$14.79 - $62.32
Target Price
$72.75
ELVN EPS estimates: the consensus estimate for Enliven Therapeutics, Inc.'s current fiscal year is -$1.75 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ELVN EPS Estimates
- EPS estimate, current quarter
- $-0.46
- EPS estimate, next quarter
- $-0.57
- EPS estimate, current year
- $-1.75
- EPS estimate, next year
- $-2.29
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.83 |
| 2024 | $-1.89 |
| 2023 | $-2.01 |
| 2022 | $0.24 |
| 2021 | $-9.48 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $40.98 | +0.9% | 1.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW